This study characterizes the prevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among hospital staff of a Belgian tertiary care center tested over 1 week in April 2020, and risk factors for seropositivity.
No takes yet. Share an insight, caveat, or question.
Steensels et al. (2020) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: